Cardio Diagnostics Holdings, Inc.CDIO

$1.98+0.00 (+0.00%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$6M

Micro-cap

-100%

2022 — today

10-Year Price

-99%

2022 — today

52-Week Range

$1.05$6.55

Current $1.98· 17%

Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.

Valuation in context

P/E ratio

-0.6

N/A

Not meaningful — company is unprofitable

P/B ratio

0.6

Historically cheap

Historically cheap relative to the last 10 years

FCF Yield

-108.3%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when CDIO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.